news-details
Health,Health Technology,Health Services,Watchlist

3 HealthTech Stocks up over 106% past 10 days

Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 106% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

Day One Biopharmaceuticals, DAWN
Summary: Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.
Recent DAWN Stock Price (approx 10:00am EST.): $16.60
Previous Close for DAWN Stock: $$15.79
Percentage Price Change Past 10 Days for DAWN stock: +131% 

TipRanks.com reports that Day One Biopharmaceuticals stock currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating for DAWN stock with an average price target is $37.50. 

Click here to get the full story on DAWN stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Clovis Oncology, CLVS
Summary: Clovis Oncology, Inc. is a biopharmaceutical companyfocused on acquiring, developing and commercializing innovative anti-cancer agents.'Clovis has only one marketed drug in its portfolio a poly ADP-ribose polymerase inhibitor, namely Rubraca that is approved for the treatment of certain patients with ovarian and prostate cancer.' Currently, Rubraca is approved in the United States for two indications specific to ovarian cancer in the second and third or later-line setting.
Recent CLVS Stock Price (approx 10:00am EST.): $1.79
Previous Close for CLVS Stock: $$1.64
Percentage Price Change Past 10 Days for CLVS stock: +111% 

Click here to get the full story on CLVS stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Cogent Biosciences, COGT
Summary: Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.
Recent COGT Stock Price (approx 10:00am EST.): $9.67
Previous Close for COGT Stock: $$9.46
Percentage Price Change Past 10 Days for COGT stock: +106% 

TipRanks.com reports that Cogent Biosciences stock currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for COGT stock with an average price target is $22.00. 

Click here to get the full story on COGT stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

The other great tool for charting is TradingView.com, so you might want to check that out too.

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.